Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.
Recent evidence has raised in discussion the possibility that cannabidiol can act as a negative allosteric modulator of the cannabinoid type 1 receptor. Here we have used computational methods to study the modulation exerted by cannabidiol on the effects of delta-9-tetrahydrocannabinol in the cannab...
Main Authors: | Hery Chung, Angélica Fierro, C David Pessoa-Mahana |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0220025 |
Similar Items
-
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
by: Paul T. Kocis, et al.
Published: (2020-07-01) -
Impact of the cannabinoid delta-9-tetrahydrocannabinol on plancental leptin regulation
by: Débora Sofia Alves Gonçalves
Published: (2020) -
Synthetic cannabinoids versus delta-9-tetrahydrocannabinol: abuse-related consequences of enhanced efficacy at the cannabinoid 1 receptor
by: Grim, Travis
Published: (2015) -
Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
by: Patricia Golombek, et al.
Published: (2020-06-01) -
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
by: Eva Martínez-Pinilla, et al.
Published: (2017-10-01)